ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,330, issued on Feb. 3, was assigned to DRIVE THERAPEUTICS LLC (Chapel Hill, N.C.) and ALBERT EINSTEIN COLLEGE OF MEDICINE (Bronx, N.Y.).
"Stem-loop compositions and methods for inhibiting vascular endothelial growth factor" was invented by Carl Erickson (Corte Madera, Calif.), Christopher P. Rusconi (Durham, N.C.), Matthew Levy (Chapel Hill, N.C.), Keith E. Maier (Durham, N.C.), Sarah E. Thacker (Fuquay-Varina, N.C.) and Derek Parks (Raleigh, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The application discloses methods and compositions for inhibiting functions associated with vascular endothelial growth factor-A (VEGF-A). The methods and comp...